AML: Transcription Factors Driving Venetoclax Resistance

Università di Torino seeks a researcher to study transcription factors mediating resistance to therapies in acute myeloid leukemia, focusing on BCL-2 inhibitor venetoclax. The project uses molecular techniques and cellular assays to uncover resistance mechanisms. The candidate must hold a Laurea Magistrale or equivalent and be within six years of the degree date; further details are available in the official call published by the university. #J-18808-Ljbffr